Amplia Therapeutics Ltd.ASX: ATX

Amplia Reports First Patient Dosing In Phase 2a Accent Trial

Jan 17, 2024 at 2:37 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment